Evidence map›Paper›PMID 28173143›Full record

ArticleHuman molecular genetics2016

Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4.

Jocelyn O Eidahl, Carlee R Giesige, Jacqueline S Domire, Lindsay M Wallace, Allison M Fowler, Susan M Guckes, Sara E Garwick-Coppens, Paul Labhart, Scott Q Harper

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Deciphering Facioscapulohumeral Dystrophy in the clinical trials era: where are we now?Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2025
    Review
  7. The role(s) of NF-Y in development and differentiation.Cell death and differentiation · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Genome architecture and totipotency: An intertwined relation during early embryonic development.BioEssays : news and reviews in molecular, cellular and developmental biology · 2022
    Article
  15. Review
  16. DUX: One Transcription Factor Controls 2-Cell-like Fate.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jocelyn O EidahlCenter for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Carlee R GiesigeCenter for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Jacqueline S DomireCenter for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Lindsay M WallaceCenter for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Allison M FowlerCenter for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Susan M GuckesCenter for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Sara E Garwick-CoppensCenter for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Paul LabhartActive Motif, Carlsbad, CA, USA.
Scott Q HarperCenter for Gene Therapy, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Nationwide Children's Hospital · USActive Motif (United States) · US

Funding

Myogenesis Studies for FSHD BiomarkersU54HD060848 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI EMERSON, CHARLES P. · 2008 to 2017
$16.1M
Training and Education CoreU54HD066409 · NICHD · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI MARTIN, PAUL TAYLOR · 2010 to 2014
$6.7M
DUX4 and the P53 pathway in FSHD pathogenesisR01AR062123 · NIAMS · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI HARPER, SCOTT Q · 2012 to 2016
$1.6M
Training in neuromuscular diseasesT32NS077984 · NINDS · OHIO STATE UNIVERSITY · PI GUTTRIDGE, DENIS C, MENDELL, JERRY ROY · 2012 to 2016
$946k
The Ohio State University Center for Clinical and Translational ScienceTL1TR001069 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$763k
NCATS NIH HHS TL1 TR001069NIAMS NIH HHS R01 AR062123NICHD NIH HHS U54 HD060848NICHD NIH HHS U54 HD066409NINDS NIH HHS T32 NS077984
6 · The paper itself

Abstract

D4Z4 repeats are present in at least 11 different mammalian species, including humans and mice. Each repeat contains an open reading frame encoding a double homeodomain (DUX) family transcription factor. Aberrant expression of the D4Z4 ORF called DUX4 is associated with the pathogenesis of Facioscapulohumeral muscular dystrophy (FSHD). DUX4 is toxic to numerous cell types of different species, and over-expression caused dysmorphism and developmental arrest in frogs and zebrafish, embryonic lethality in transgenic mice, and lesions in mouse muscle. Because DUX4 is a primate-specific gene, questions have been raised about the biological relevance of over-expressing it in non-primate models, as DUX4 toxicity could be related to non-specific cellular stress induced by over-expressing a DUX family transcription factor in organisms that did not co-evolve its regulated transcriptional networks. We assessed toxic phenotypes of DUX family genes, including DUX4, DUX1, DUX5, DUXA, DUX4-s, Dux-bl and mouse Dux. We found that DUX proteins were not universally toxic, and only the mouse Dux gene caused similar toxic phenotypes as human DUX4. Using RNA-seq, we found that 80% of genes upregulated by Dux were similarly increased in DUX4-expressing cells. Moreover, 43% of Dux-responsive genes contained ChIP-seq binding sites for both Dux and DUX4, and both proteins had similar consensus binding site sequences. These results suggested DUX4 and Dux may regulate some common pathways, and despite diverging from a common progenitor under different selective pressures for millions of years, the two genes maintain partial functional homology.

Indexed as

Gene Regulatory NetworksAmino Acid SequenceAnimalsCell LineChromatin ImmunoprecipitationEvolution, MolecularHomeodomain ProteinsHumansMiceMice, TransgenicMuscular Dystrophy, FacioscapulohumeralMycotoxinsMyoblastsSequence AlignmentSequence Analysis, RNADUX4L1 protein, humanHomeodomain ProteinsMycotoxins

Identifiers

PMID28173143
PMCPMC5409219
OpenAlexW2508999286

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.